Amniotic stem cell therapy is now mainstream, and because it’s fairly new people have lots of questions about the treatment. The therapy is extremely low risk, and contains several “ingredients” that are beneficial for repair and regeneration of tendons, ligaments, cartilage and other tissues. While a lot of products on the market have no live stem cells after processing, there are some that do. Hear R3 Stem Cell describe the top 8 things to know about amniotic stem cell treatment.
Dr. David Greene
MD, PhD, MBA
Dr. David Greene, MD, PhD, MBA, is a pioneering leader in regenerative medicine and healthcare marketing. As a residency and fellowship-trained orthopedic surgeon, Dr. Greene transitioned from clinical practice to become the founder and CEO of R3 Stem Cell and US Lead Network, where he has revolutionized patient care and medical practice growth through innovative therapies and digital marketing strategies. He has authored two influential books on healthcare internet marketing, ranks among the top expert authors globally, and has been featured on the cover of Corporate Vision magazine for his impact on global regenerative therapies. Beyond his professional achievements, Dr. Greene is passionate about education, compassion, and continuous innovation.
Sorry, the comment form is closed at this time.